GSK plc
—- Market cap
- $104.93B
- Debt
- —
- Cash
- −$4.61B
USD conversion input: 1 GBP = 1.356500 USD. FX date unavailable.
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $104.93B · View financials
Snapshot Sep 9, 2026, 4:00 PM ET
FY 2025 ·
Decision snapshot: GSK stock price at discount vs IRDM $48.63 current versus $167.18 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at IRDM's multiple
Implied fair value · at GSK's multiple
Snapshot Sep 9, 2026, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Lower P/E
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
USD conversion input: 1 GBP = 1.356500 USD. FX date unavailable.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 74% equity / 26% debt · EV / Revenue 7.63x · EV proxy / EBITDA proxy 14.91x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
GSK plc · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Iridium Communications Inc. · implied price per share
Bear
$18.25
Base
$24.19
Bull
$31.93
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
PFIZER INC
GSK vs PFE
ELI LILLY & Co
GSK vs LLY
BRISTOL MYERS SQUIBB CO
GSK vs BMY
JOHNSON & JOHNSON
GSK vs JNJ
AbbVie Inc.
GSK vs ABBV
AMGEN INC
GSK vs AMGN
AST SpaceMobile, Inc.
GSK vs ASTS
VIASAT INC
GSK vs VSAT
L3HARRIS TECHNOLOGIES, INC. /DE/
GSK vs LHX
Globalstar, Inc.
GSK vs GSAT
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.